Related references
Note: Only part of the references are listed.A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis
Rui Liu et al.
EUROPEAN JOURNAL OF CANCER (2011)
Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response
Angelique Gougelet et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
MicroRNA-199a-3p Is Downregulated in Human Osteosarcoma and Regulates Cell Proliferation and Migration
Zhenfeng Duan et al.
MOLECULAR CANCER THERAPEUTICS (2011)
MicroRNA-143 Regulates Human Osteosarcoma Metastasis by Regulating Matrix Metalloprotease-13 Expression
Mitsuhiko Osaki et al.
MOLECULAR THERAPY (2011)
MicroRNA-21 is involved in osteosarcoma cell invasion and migration
Wu Ziyan et al.
MEDICAL ONCOLOGY (2011)
MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells
Francesca Fornari et al.
CANCER RESEARCH (2010)
Circulating MicroRNAs in Patients With Coronary Artery Disease
Stephan Fichtlscherer et al.
CIRCULATION RESEARCH (2010)
Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes
Anna Zampetaki et al.
CIRCULATION RESEARCH (2010)
Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non-Small-Cell Lung Cancer
Zhibin Hu et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples
Chunlei He et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), Amplified on Chromosome 9, Collaborate with p53 Deficiency in Mouse Osteosarcoma Progression
Ou Ma et al.
CANCER RESEARCH (2009)
Identification of novel microRNA targets based on microRNA signatures in bladder cancer
Takahiro Ichimi et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Role of miR-143 targeting KRAS in colorectal tumorigenesis
X. Chen et al.
ONCOGENE (2009)
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells
B. Song et al.
ONCOGENE (2009)
Decreased Expression of MicroRNA-143 and -145 in Human Gastric Cancers
Takeshi Takagi et al.
ONCOLOGY (2009)
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Shuomin Zhu et al.
CELL RESEARCH (2008)
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
Xi Chen et al.
CELL RESEARCH (2008)
Osteosarcoma development and stem cell differentiation
Ni Tang et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
I. A. Asangani et al.
ONCOGENE (2008)
Downregulation of microRNAs-143 and-145 in B-cell malignancies
Yukihiro Akao et al.
CANCER SCIENCE (2007)
MicroRNA signatures in human ovarian cancer
Marilena V. Iorio et al.
CANCER RESEARCH (2007)
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
Fanyin Meng et al.
GASTROENTEROLOGY (2007)
MicroRNA expression profiling in prostate cancer
Kati P. Porkka et al.
CANCER RESEARCH (2007)
Patterns of known and novel small RNAs in human cervical cancer
Weng-Onn Lui et al.
CANCER RESEARCH (2007)
MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1)
Shuomin Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy - 15-year experience in 789 patients treated at a single institution
G Bacci et al.
CANCER (2006)
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
JA Chan et al.
CANCER RESEARCH (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup
EI Hauben et al.
EUROPEAN JOURNAL OF CANCER (2002)
Prognostic factors in high-grade osteosarcoma of the extremities or trunk:: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols
SS Bielack et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
